These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 7875058)

  • 41. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections. A multicenter trial.
    Gentry LO; Ramirez-Ronda CH; Rodriguez-Noriega E; Thadepalli H; del Rosal PL; Ramirez C
    Arch Intern Med; 1989 Nov; 149(11):2579-83. PubMed ID: 2684078
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections.
    Iravani A
    Am J Med; 1993 Mar; 94(3A):89S-96S. PubMed ID: 8452189
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
    Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
    Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral ciprofloxacin treatment of infections in geriatric patients.
    Yangco BG; Kenyon VS; Halkias KD; Bogel JA; Toney JF; Chmel H
    Clin Ther; 1989; 11(4):503-10. PubMed ID: 2776166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
    J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical experience with ciprofloxacin: analysis of a multicenter study.
    Karimi K
    Indiana Med; 1990 Apr; 83(4):266-9. PubMed ID: 2185309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study.
    Terzi C; Kiliç D; Unek T; Hoşgörler F; Füzün M; Ergör G
    J Hosp Infect; 2005 Aug; 60(4):340-7. PubMed ID: 16002019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of urinary tract infections with ciprofloxacin after renal transplantation.
    Grekas D; Thanos V; Dioudis C; Alivanis P; Tourkantonis A
    Int J Clin Pharmacol Ther Toxicol; 1993 Jun; 31(6):309-11. PubMed ID: 8335429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
    Nix DE; Cumbo TJ; Kuritzky P; DeVito JM; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):146-53. PubMed ID: 3555029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).
    Ten Doesschate T; van Mens SP; van Nieuwkoop C; Geerlings SE; Hoepelman AIM; Bonten MJM
    BMC Infect Dis; 2018 Dec; 18(1):626. PubMed ID: 30518334
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience.
    Pavoni GL; Giannella M; Falcone M; Scorzolini L; Liberatore M; Carlesimo B; Serra P; Venditti M
    Clin Microbiol Infect; 2004 Sep; 10(9):831-7. PubMed ID: 15355415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective, randomized, controlled study comparing two dosing regimens of gentamicin/oral ciprofloxacin switch therapy for acute pyelonephritis.
    Bailey RR; Begg EJ; Smith AH; Robson RA; Lynn KL; Chambers ST; Barclay ML; Hornibrook J
    Clin Nephrol; 1996 Sep; 46(3):183-6. PubMed ID: 8879853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections.
    Wollschlager CM; Raoof S; Khan FA; Guarneri JJ; LaBombardi V; Afzal Q
    Am J Med; 1987 Apr; 82(4A):164-8. PubMed ID: 3555030
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ciprofloxacin in the treatment of urinary and respiratory tract infections in patients with chronic liver disease.
    Galante D; Esposito S; Barba D; Giusti G
    Chemioterapia; 1986 Oct; 5(5):322-6. PubMed ID: 3791479
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of ciprofloxacin in the treatment of various bacterial infections.
    Phillips HL; Nolen TM; Hutchison J
    Ala Med; 1989 Apr; 58(10):28-32. PubMed ID: 2729030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin.
    Scully BE; Jules K; Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):336-8. PubMed ID: 3578324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Oral antibiotic therapy in the adult bacterial osteomyelitis: results after two years of follow-up].
    Javaloyas de Morlius M; Monreal Portella M
    Med Clin (Barc); 1999 Oct; 113(13):488-9. PubMed ID: 10604172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.